Marcello Maida
University of Palermo
Internal medicineRadiologySurgeryOncologyProspective cohort studyAdverse effectObservational studySteatosisEndoscopic submucosal dissectionCirrhosisHepatocellular carcinomaInflammatory bowel diseaseTolerabilityColonoscopySorafenibDiseaseCrohn's diseaseUlcerative colitisIn patientIncidence (epidemiology)MedicineCohortGastroenterologyMeta-analysis
148Publications
20H-index
1,434Citations
Publications 144
Newest
Source
Source
Source
Source
Source
Source
Source
#1Federica Crispino (University of Palermo)
#2Mauro Grova (University of Palermo)H-Index: 1
Last. Ambrogio OrlandoH-Index: 35
view all 12 authors...
Objective: There is a growing need for inflammatory biomarkers to predict therapeutic outcome in Crohn's disease (CD) patients.Main outcome measures: The aim was to evaluate whether NLR (neutrophil-to-lymphocyte ratio), PLR (platelet-to-lymphocyte ratio), ELR (eosinophil-to-lymphocyte ratio) and ENLR (eosinophil*neutrophil-to-lymphocyte ratio), could be prognostic biomarkers of endoscopic response (ER) when starting biologics.Research design and methods: Patients with CD who started biologics we...
Source
Source
Source